Association between family history and mismatch repair in colorectal cancer

Coggins, R. P.; Cawkwell, L.; Bell, S. M.; Crockford, G. P.; Quirke, P.; Finan, P. J.; Bishop, D. T.
May 2005
Gut;May2005, Vol. 54 Issue 5, p636
Academic Journal
Background and aims: Germline mutations in mismatch repair (MMR) genes cause a greatly increased risk of cancer of the gastrointestinal and female reproductive tracts (hereditary non-polyposis colorectal cancer (HNPCC)). Loss of MMR expression is common in colorectal cancer (CRC) overall. Such loss is assumed to be acquired predominantly, although a population of CRC cases will include individuals with unrecognised MMR mutations. This study examines the association between MMR gene expression and family history of cancer among the CRC population. Methods: Individuals with CRC were identified from two well characterised populations: (1) consecutive hospital patients (n = 644) and (2) a population based cases series (n = 249). CRC was examined for expression of hMLH1 and 6MSH2 using immunohistochemistry, and expression was related to family history using logistic regression. Results: hMLH1 and hMSH2 expression was assessed in 732 CRCs with 8% showing loss of expression. No association was seen overall for hMLH1 or hMSH2 expression and family history of CRC. Loss of hMSH2 was predicted by family history of extracolonic cancer (odds ratio (OR) 5.78 (95% confidence interval (CI) 0.95-35.18)) and family history suggestive of HNPCC (OR 27.84 (95% CI 4.37-177.56)). Loss of hMLH 1 was not predicted by family history of extracolonic cancer or a family history suggestive of HNPCC but was for a family history of at least two affected relatives (OR 4.88 (95% Cl 1.25-19.03)). Conclusions: Individuals with hMSH2 deficient CRC in the general population exhibit a family history and other characteristics suggestive of HNPCC, and may carry germline MMR mutations. Loss of hMIH1 is only associated with a strong family history of extracolonic cancer at older ages, suggesting a novel mechanism of susceptibility.


Related Articles

  • Wnt signalling induces maturation of Paneth cells in intestinal crypts. van Es, Johan H.; Jay, Philippe; Gregorieff, Alex; van Gijn, Marielle E.; Jonkheer, Suzanne; Hatzis, Pantelis; Thiele, Andrea; van den Born, Maaike; Begthel, Harry; Brabletz, Thomas; Taketo, Makoto M.; Clevers, Hans // Nature Cell Biology;Apr2005, Vol. 7 Issue 4, p381 

    Wnt signalling, which is transduced throughß-catenin/TCF4, maintains the undifferentiated state of intestinal crypt progenitor cells. Mutational activation of the pathway initiates the adenomacarcinoma sequence. Whereas all other differentiated epithelial cells migrate from the crypt onto the...

  • Two mismatch repair gene mutations found in a colon cancer patient – which one is pathogenic? Kariola, Reetta; Otway, Robyn; Lönnqvist, Karin E.; Raevaara, Tiina E.; Macrae, Finlay; Vos, Yvonne J.; Kohonen-Corish, Maija; Hofstra, Robert M.; Nyström-Lahti, Minna // Human Genetics;Feb2003, Vol. 112 Issue 2, p105 

    Hereditary nonpolyposis colorectal cancer (HNPCC) is a dominantly inherited cancer syndrome. Germline mutations in five different mismatch repair (MMR) genes, MSH2, MSH6, MLH1, MLH3, and PMS2 are linked to HNPCC. Here, we describe two colon cancer families in which the index patients carry...

  • Mutations in the WTX - gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers. K.^Scheel, Silvio; Porzner, Marc; Pfeiffer, Sabine; Ormanns, Steffen; Kirchner, Thomas; Jung, Andreas // BMC Cancer;2010, Vol. 10, p413 

    Background: Genetically, colorectal cancers (CRCs) can be subdivided into tumors with chromosomal instability (CIN) or microsatellite instability (MSI). In both types of CRCs genes that are involved in the degradation of β- CATENIN are frequently mutated. Whereas in CIN CRCs APC (Adenomatous...

  • Loss of Cdx2 expression in primary tumors and lymph node metastases is specific for mismatch repair-deficiency in colorectal cancer. Dawson, Heather; Koelzer, Viktor H.; Lukesch, Anne C.; Mallaev, Makhmudbek; Inderbitzin, Daniel; Lugli, Alessandro; Zlobec, Inti // Frontiers in Oncology;Oct2013, Vol. 3, p1 

    Background: Approximately 20% of all colorectal cancers are hypothesized to arise from the "serrated pathway" characterized by mutation in BRAF, high-level CpG Island Methylator Phenotype, and microsatellite instability/mismatch repair (MMR)-deficiency. MMRdeficient cancers show frequent losses...

  • Altered gene expression and miRNA expression associated with cancerous IEC-6 cell transformed by MNNG. Bo Zhang; Xukai Wang; Yan Wang // Journal of Experimental & Clinical Cancer Research (17569966);2009, Vol. 28, p1 

    Background: Tumorigenesis is thought to be the consequence of gene mutation and disordered gene expression. However, the detailed molecular mechanism underlying the development and progress of colon cancer have not been elucidate completely. This study aimed to find out the genes associated with...

  • Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy. Maus, M K H; Hanna, D L; Stephens, C L; Astrow, S H; Yang, D; Grimminger, P P; Loupakis, F; Hsiang, J H; Zeger, G; Wakatsuki, T; Barzi, A; Lenz, H-J // Pharmacogenomics Journal;Aug2015, Vol. 15 Issue 4, p354 

    Colorectal cancer (CRC) is a heterogeneous disease with genetic profiles and clinical outcomes dependent on the anatomic location of the primary tumor. How location has an impact on the molecular makeup of a tumor and how prognostic and predictive biomarkers differ between proximal versus distal...

  • RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas. Deb, S; Xu, H; Tuynman, J; George, J; Yan, Y; Li, J; Ward, R L; Mortensen, N; Hawkins, N J; McKay, M J; Ramsay, R G; Fox, S B // British Journal of Cancer;3/11/2014, Vol. 110 Issue 6, p1606 

    Background:RAD21 is a component of the cohesion complex and is integral to chromosome segregation and error-free DNA repair. RAD21 is functionally important in tumour progression but its role in colorectal carcinoma (CRC) is unclear. We therefore assessed its clinicopathological and prognostic...

  • Response. Lochhead, Paul; Meyerhardt, Jeffrey A.; Fuchs, Charles S.; Ogino, Shuji // JNCI: Journal of the National Cancer Institute;Aug2014, Vol. 106 Issue 8, p1 

    A letter to the editor is presented in response to the article "Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803," by S. Ogino and colleagues in issue number 2012; 18(3).

  • Re: Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication. Rosty, Christophe; Williamson, Elizabeth J.; Clendenning, Mark; Walters, Rhiannon J.; Walsh, Michael D.; Win, Aung K.; Jenkins, Mark A.; Hopper, John L.; Winship, Ingrid; Southey, Melissa C.; Giles, Graham G.; English, Dallas R.; Buchanan, Daniel D. // JNCI: Journal of the National Cancer Institute;Aug2014, Vol. 106 Issue 8, p1 

    A letter to the editor is presented in response to the article "Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication," by P. Lochhead and colleagues in issue number 105 (15).


Read the Article


Sign out of this library

Other Topics